TINCR and metastatic neoplasm: Finally, extended analysis of homogeneously treated and clinically annotated tumor cohorts will be instrumental in better defining the association of loss of TINCR protein expression with aggressive poorly differentiated tumor histopathology, metastatic disease, and outcomes.